Key Proteo, Inc.
Sean Sandin has an extensive background in grants and contracts management, with experience at various research institutes and organizations. Currently serving as Chief Operating Officer at Key Proteo, Inc., Sean has also held roles such as Grants and Contracts Senior, Center Business Manager, and Grants and Contracts Analyst. With a Bachelor's degree in Communication from Seattle Pacific University, Sean's expertise lies in sponsored research oversight, budget management, and contract administration. Prior to their current position, Sean also gained experience in the medical field as a Radiology Assistant and Surgical Scheduler. Additionally, Sean has significant experience as a Premier head soccer coach for over 5 years.
This person is not in any teams
Key Proteo, Inc.
Key Proteo is democratizing the early detection of rare but treatable genetic disorders through novel and accessible proteomic analysis. As a pioneering proteomics company, Key Proteo is initially focused on the early detection of treatable rare genetic disorders in newborns, with the goal of expanding newborn screening to identify extremely low abundance protein biomarkers that were previously undetectable. Many treatable genetic disorders are difficult to detect, but when found early, intervention can be enabled to help change the clinical course. Ultimately, our mission is to relieve suffering and save lives for patients and their families afflicted by rare but treatable genetic disorders through early screening.